Pak J. Pharma. Instructions
Pak J. Pharma. Instructions
Title: Title of the manuscript should cover the aim, object and comprehensive accounts of
significant experimental or theoretical work.
Authors’ citation: Name of authors must be given as per their contribution and their
participation clearly must be mentioned in Undertaking Form. Name of authors will not be
increased and replaced with other names after initial submission in any stage i.e. modification,
revision and galley proof.
Abstract: An abstract should be concise (80-200 words) self- contained summary, should
include the background/objective, purpose of the study (including its statistical significance),
methods, results and conclusion.
Keywords: For indexing purposes each submitted article should include three to five key words
chosen from the medical subject heading (MeSH). In addition to facilitating indexing of articles,
our keyword system assists in the assignment of qualified reviewers for your manuscript.
Materials and Methods: The experimental procedures should be described in sufficient detail
to enable others to repeat the experiments. Names of products and manufacturers should be
included only if alternate sources are deemed unsatisfactory. Novel experimental procedures
should be described in detail, but published procedures should merely be referred to by
literature citation of both the original and any published modifications. The purity of key
compounds and descriptions(s) of the method(s) used to determine purity should be included in
this section.
Ethical approval: Manuscripts containing data generated from animal and/or human studies
must specify the committee and the institution that approved the experimental protocols used to
generate these data.
Statistical analysis: Authors should mention the software and version used in research article
with test applied for analysis.
Results: Concise tables and figures should be designed to maximize the presentation and
comprehension of the experimental data. The same data should not be presented in more than
one figure or in both a figure and a table. As a rule, interpretation of the results should be
reserved for the discussion section of an article.
Discussion: The purpose of the discussion is to interpret the results and to relate them to
existing knowledge in the field in as clear and brief a fashion as possible. Information given
elsewhere in the manuscript should not be repeated in the discussion. Extensive reviews of the
literature should be avoided.
Conflict of interest: Authors will include statement about no conflict of interest.
For journals: Yoneto K, Li SK, Higuchi WI, Jiskoot W and Herron JN (1996). Fluorescence probe
studies of the interactions of 1-alkyl- 2-pyrrolidones with stratum corneum lipid liposomes. J.
Pharm. Sci., 85(5): 511-517. For edited books: Rall TW and Schleifer LS (1985). Drugs effective
in the therapy of the epilepsies. In: Gilman AG, Goodman LS, Rall TW, Murad F editors. The
pharmacological basis of therapeutics, 7th ed., MacMillan Publishing Co., New York, pp.446-
472.
Tables: Tabulation of experimental results is encouraged when this leads to more effective
presentation or to more economical use of space, tables should be numbered consecutively
with Arabic numerals with a brief title and a brief heading for each column. Clearly indicate the
units of measure (preferably SI) and preferred in *.doc format.
Submission of undertaking: The all concerned authors are bound to submit an undertaking
duly original signed by them, which shows that this paper has not been submitted elsewhere
and is also not plagiarized according to the policy of Higher Education Commission, Islamabad,
Pakistan, contributors of all authors are also required to mention against their names.